Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)
NCT05113849
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
IN-B009 (Low-dose)
BIOLOGICAL:
IN-B009 (High-dose)
Sponsor
HK inno.N Corporation